BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 23968282)

  • 1. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.
    Rosário C; Zandman-Goddard G; Meyron-Holtz EG; D'Cruz DP; Shoenfeld Y
    BMC Med; 2013 Aug; 11():185. PubMed ID: 23968282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperferritinemic syndrome: Still's disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients.
    Betancur JF; Navarro EP; Echeverry A; Moncada PA; Cañas CA; Tobón GJ
    Clin Rheumatol; 2015 Nov; 34(11):1989-92. PubMed ID: 26233722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferritin, fever, and frequent visits: Hyperferritinemic syndromes in the emergency department.
    Annous Y; Manning S; Khoujah D
    Am J Emerg Med; 2021 Oct; 48():249-254. PubMed ID: 34000525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperferritinaemia: An Iron Sword of Autoimmunity.
    Giemza-Stokłosa J; Islam MA; Kotyla PJ
    Curr Pharm Des; 2019; 25(27):2909-2918. PubMed ID: 31686632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
    Ruscitti P; Di Cola I; Di Muzio C; Italiano N; Ursini F; Giacomelli R; Cipriani P
    Autoimmun Rev; 2022 Jul; 21(7):103114. PubMed ID: 35595050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
    Colafrancesco S; Alessandri C; Conti F; Priori R
    Autoimmun Rev; 2020 Jul; 19(7):102573. PubMed ID: 32387470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
    Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
    J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
    Kawasaki T; Ooka S; Mizushima M; Nakamura Y; Ikeda H; Sakurada T; Suzuki S; Yamazaki K; Goto Y; Sakurai K; Yukitaka Y; Kiyokawa T; Tonooka K; Kunishima H; Kawahata K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):101-105. PubMed ID: 34592766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low density lipoprotein, chylomicron, and lipoprotein (a) are more useful to detect the development of macrophage activation syndrome in adult-onset still's disease as compared with cytokines and triglyceride.
    Yanai H; Moriyama S; Hirowatari Y; Kaneko H
    Am J Hematol; 2013 Sep; 88(9):828-30. PubMed ID: 23760887
    [No Abstract]   [Full Text] [Related]  

  • 11. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
    PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.
    Zhu D; Chen L; Meng J; Wang M; Ma Y; Chen X; Xiao Y; Yi D; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Zhou Z; Yang C; Teng J; Jia J; Hu Q
    J Autoimmun; 2024 Apr; 144():103182. PubMed ID: 38460457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ferritin levels in adult Still's disease].
    Flatau E; Reichman N; Kaufman N
    Harefuah; 1999 Sep; 137(5-6):200-1, 263, 262. PubMed ID: 10959321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of glycosylated ferritin with Concanavalin A: Assay design, optimization and validation.
    Raynor A; Peoc'h K; Boutten A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123184. PubMed ID: 35240430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome.
    Coffernils M; Soupart A; Pradier O; Feremans W; Nève P; Decaux G
    J Rheumatol; 1992 Sep; 19(9):1425-7. PubMed ID: 1433011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
    Gulzar M; Sabir A; Hamdani MA; Saadia A
    J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?
    Ruscitti P; Berardicurti O; Barile A; Cipriani P; Shoenfeld Y; Iagnocco A; Giacomelli R
    Ann Rheum Dis; 2020 Nov; 79(11):1515-1516. PubMed ID: 32434816
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.